Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income	$ 1,335	$ 1,722
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, (accretion) and amortization	162	183
Stock-based compensation expense	349	260
Deferred income tax expense	241
Provision for credit losses		7
ESOP expense	86	78
Increase in cash surrender value of bank owned life insurance	(98)	(87)
Change in:
Accrued interest receivable and other assets	(525)	(779)
Accrued interest payable and other liabilities	(333)	615
Net cash provided by operating activities	1,217	1,999
Cash flows from investing activities:
Purchases of investment securities held-to-maturity		(7,609)
Purchases of investment securities available-for-sale		(5,710)
Purchases of premises and equipment	(132)	(148)
Proceeds from paydowns of investment securities available-for-sale	375	1,379
Proceeds from paydowns of investment securities held-to-maturity	24	15
Purchases of other investments	(46)	(2,339)
Proceeds from sales of other investments		425
Net change in loans	(14,906)	(15,226)
Net cash used in investing activities	(14,685)	(29,213)
Cash flows from financing activities:
Net change in deposits	13,001	93,668
Stock repurchase		(867)
Proceeds from FHLB advances		65,000
Repayment of FHLB advances		(20,000)
Repayment of federal funds purchased		(25)
Proceeds from other borrowings	11,837
Net cash provided by financing activities	24,838	137,776
Net change in cash and cash equivalents	11,370	110,562
Cash and cash equivalents at beginning of period	50,025	26,324
Cash and cash equivalents at end of period	61,395	136,886
Supplemental disclosures of cash flow information:
Cash paid for interest	4,791	2,372
Change in unrealized gain on investment securities available-for-sale, net of tax	$ 14	$ 474